INFECTIOUS THYROIDITIS

INFECTIOUS THYROIDITIS was reported 102 times

INFECTIOUS THYROIDITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 Tyrosine Kinase 2 Inhibitor [EPC] 1 0.0003
2 Lipid-based Polyene Antifungal [EPC] 4 0.0003
3 Thyroid Hormone Synthesis Inhibitor [EPC] 3 0.0003
4 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0002
5 Polyene Antifungal [EPC] 8 0.0002
6 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
7 Provitamin D2 Compound [EPC] 3 0.0001
8 Penem Antibacterial [EPC] 3 0.0001
9 Bile Acid Sequestrant [EPC] 1 0.0001
10 Asparagine-specific Enzyme [EPC] 1 0.0001
11 Stimulant Laxative [EPC] 1 0.0001
12 Glycopeptide Antibacterial [EPC] 4 0.0001
13 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
14 Janus Kinase Inhibitor [EPC] 9 0.0001
15 Vitamin D Analog [EPC] 1 0.0001
16 Interleukin-17A Antagonist [EPC] 2 0.0001
17 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 5 0.0001
18 Vitamin D3 Analog [EPC] 1 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 21 0.0000
20 Progesterone [EPC] 1 0.0000
21 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
22 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
23 Corticosteroid [EPC] 48 0.0000
24 Microtubule Inhibitor [EPC] 6 0.0000
25 Azole Antifungal [EPC] 5 0.0000
26 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
27 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
28 Kinase Inhibitor [EPC] 17 0.0000
29 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
30 Nucleoside Analog Antiviral [EPC] 2 0.0000
31 Platinum-based Drug [EPC] 6 0.0000
32 Alkylating Drug [EPC] 5 0.0000
33 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 16 0.0000
35 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
36 Interferon beta [EPC] 3 0.0000
37 Fluoroquinolone Antibacterial [EPC] 2 0.0000
38 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
39 Tetracycline-class Drug [EPC] 1 0.0000
40 Integrin Receptor Antagonist [EPC] 1 0.0000
41 Insulin Analog [EPC] 5 0.0000
42 Osmotic Laxative [EPC] 3 0.0000
43 Purine Antimetabolite [EPC] 1 0.0000
44 Antirheumatic Agent [EPC] 1 0.0000
45 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
46 Aromatase Inhibitor [EPC] 1 0.0000
47 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
48 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
49 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
50 Sulfonylurea [EPC] 1 0.0000
51 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
52 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
53 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
54 Factor Xa Inhibitor [EPC] 2 0.0000
55 Platelet Aggregation Inhibitor [EPC] 4 0.0000
56 Calcium [EPC] 1 0.0000
57 beta-Adrenergic Blocker [EPC] 2 0.0000
58 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
59 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
60 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
61 Estrogen [EPC] 1 0.0000
62 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
63 Proton Pump Inhibitor [EPC] 3 0.0000
64 Endothelin Receptor Antagonist [EPC] 1 0.0000
65 Expectorant [EPC] 1 0.0000
66 Retinoid [EPC] 1 0.0000
67 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
68 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
69 Vitamin C [EPC] 1 0.0000
70 GLP-1 Receptor Agonist [EPC] 1 0.0000
71 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
72 Thalidomide Analog [EPC] 1 0.0000
73 Benzodiazepine [EPC] 1 0.0000